sign in sign up
<<
Home , Bangka Belitung Islands, Banten, Bengkulu, Kalimantan, Lampung

Coronavirus Disease 2019 (COVID-19) World Health Organization Situation Report - 65

28 July 2021

HIGHLIGHTS

• As of 28 July, the reported 3 287 727 (47 791 new) confirmed cases of COVID 19, 88 659 (1824 new) deaths and 2 640 676 recovered cases from 510 districts across all 34 provinces.1

• From 19 to 25 July, the highest level of community transmission (CT4) was observed in seven provinces, as opposed to six in the previous week; very high incidence rates per 100 000 population were reported in DKI (688.6), DI (362.9), East (248.9), (213.3), Islands (208.1), West (198.1) and Bangka Islands (178.0). The efforts to suppress transmission through strict implementation of public health and social measures (PHSM) need to be continued and accelerated. It is critical for communities to continue practicing physical distancing, hand and respiratory hygiene, use of masks, avoiding crowded, closed and close-contact settings, and ensuring good ventilation to limit further spread of COVID-19.

Fig. 1. Geographic distribution of cumulative number of confirmed COVID-19 cases in Indonesia across the provinces reported from 22 to 28 July 2021. Source of data

Disclaimer: The number of cases reported daily is not equivalent to the number of persons who contracted COVID-19 on that day; reporting of laboratory-confirmed results may take up to one week from the time of testing.

1 https://covid19.go.id/peta-sebaran-covid19 1 WHO Indonesia Situation Report - 65 who.int/indonesia GENERAL UPDATES

• On 25 July, President announced that the enforcement of the level 4 restrictions on public activities (Pemberlakuan Pembatasan Kegiatan Masyarakat (PPKM)) will be extended until 2 August. Several adjustments to the restrictions will be made in stages and further detailed in relevant ministerial regulations. The adjustments will include allowing traditional markets selling basic daily needs to operate during normal hours. In addition, community businesses such as food stalls and street food vendors will be allowed to operate until 8:00 PM while following strict health protocols including reduced capacity to ensure proper physical distancing2. The extension of the level 4 PPKM will be implemented in 140 districts/cities of 28 provinces.3

• LaporCOVID-19, a civil society organization (CSO) which developed a citizen reporting platform for COVID-19 related data, reported that at least 2641 COVID-19 patients died in self-isolation between the beginning of June and 24 July. The deaths were recorded across 84 cities and districts in 17 provinces. The highest number of deaths was reported in DKI Jakarta (1161), followed by West (446) and DI Yogyakarta (307). On the other hand, the bed occupancy rate (BOR) in provinces outside Java has generally increased over the past two weeks. As of 23 July, LaporCOVID-19 reported that the BOR in 13 out of 34 provinces has reached above 70%, including in nine provinces outside Java. The highest BOR was recorded in DI Yogyakarta (85%).4

• On 23 July, the Head of Provincial Health Office (PHO) reported that the province was running out of oxygen supply for treating COVID-19 patients. The province has reported oxygen shortage since 14 July; however, the situation has become critical due to the recent surge of cases5. Other provinces have been experiencing a similar challenge. In Situbondo District of Province, three COVID-19 referral hospitals have reported the oxygen shortage in their facilities. On 24 July, an Acting Director of Abdoer Rahim Hospital in Situbondo District reported that the hospital only had three oxygen cylinders and limited liquid oxygen to treat their COVID-19 patients.6

2 https://en.tempo.co/read/1487287/jokowi-extends-ppkm-level-4-with-adjustments-to-restrictions 3 https://www.cnnindonesia.com/nasional/20210726072004-20-672077/daftar-lengkap-daerah-ppkm-level-4- hingga-2-agustus 4 https://www.thejakartapost.com/news/2021/07/25/more-than-2600-virus-patients-have-died-in-self-isolation- laporcovid-19.html 5 https://www.thejakartapost.com/news/2021/07/25/bali-runs-out-of-oxygen-as-president-jokowi-ponders-lifting- covid-19-curbs.html 6 https://suaraindonesia.co.id/news/peristiwa-daerah/60fbb2b0e5724/tiga-rumah-sakit-rujukan-di-situbondo- darurat-oksigen 2 WHO Indonesia Situation Report - 65 who.int/indonesia SURVEILLANCE

• On 28 July, 47 791 new and 3 287 727 cumulative cases were reported nationwide (Fig. 2). From 22 to 28 July, the average number of new cases per day was 43 414 cases; a slight decrease compared to the average of 44 826 cases per day in the previous week.

60000 3500000

50000 3000000

2500000 40000 2000000 30000 1500000 Daily number 20000 1000000 Cumulative number

10000 500000

0 0 8-Jul 2-Jan 4-Jun 9-Oct 5-Apr 5-Sep 5-Feb 2-Aug 16-Jul 25-Jul 2-Mar 9-May 1-May 19-Jan 12-Jun 29-Jun 21-Jun 26-Oct 22-Apr 14-Apr 22-Sep 22-Feb 16-Dec 19-Aug 12-Nov 29-Nov 19-Mar 11-Mar 28-Mar 26-May 18-May

Daily number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Fig. 2. Daily and cumulative number of cases reported in Indonesia, as of 28 July 2021. Source of data

Disclaimer: Since 10 February 2021, confirmed cases include those who tested positive using nucleic acid amplification test (NAAT) (e.g. polymerase chain reaction (PCR)) or antigen-detecting rapid diagnostic test (Ag-RDT). The number of cases reported daily is not equivalent to the number of persons who contracted COVID-19 on that day and might be influenced by the number of people tested on that day (see Fig. 17); reporting of laboratory-confirmed results may take up to one week from the time of testing. Therefore, caution must be taken in interpreting this figure and the epidemiological curve for further analysis, either at the national or subnational level.

3 WH O Indonesia Situation Report - 65 who.int/indonesia • During the week of 19 to 25 July, 16 out of 34 provinces continued to experience an increase in the number of cases compared to the previous week. Ten of these provinces experienced an increase of above 25%, including two with an increase of 50% or more: North Kalimantan (58%) and (50%) (Fig. 3). All provinces in Java, except for , experienced a decrease in the number of reported cases. Nevertheless, stringent public health and social measures (PHSM) should continue to be implemented throughout the country.

North Kalimantan South Kalimantan Southeast Bali North Central Java Riau Papua East Java North DI Yogyakarta Maluku DKI Jakarta -60% -40% -20% 0% 20% 40% 60% Percentage change of weekly number of confirmed cases

Fig. 3. Percentage change of weekly number of confirmed cases by province during 19 to 25 July 2021 compared to the previous week. Source of data

Disclaimer: The number of weekly confirmed cases is calculated taking into consideration the daily number of reported cases. It is important to conduct further investigation if there is a substantial change in new cases, especially in provinces with a change of 50% or more. Other factors, such as testing and contact tracing, may help elucidate the reasons behind substantial changes. Additional indicators, including case incidence and mortality, should be considered to guide adjustment of PHSM. 4 WHO Indonesia Situation Report - 65 who.int/indonesia

• During the week of 19 to 25 July, the incidence7 of COVID-19 cases in Indonesia increased substantially from 95.6 per 100 000 population in the previous week to 114.0 per 100 000 population (Fig. 4). The incidence has been rapidly increasing in the country since mid-May and is almost four-fold greater than the previously recorded highest incidence in February (31.5 per 100 000 population).

120

105

90 CT3 (50 - <150) 75

60

Case incidence 45 CT2 (20 - <50) 30

15 CT1 (<20) 0 13/04 - 19/04 27/04 - 03/05 11/05 - 17/05 25/05 - 31/05 08/06 - 14/06 22/06 - 28/06 06/07 - 12/07 20/07 - 26/07 03/08 - 09/08 17/08 - 23/08 31/08 - 06/09 14/09 - 20/09 28/09 - 04/10 12/10 - 18/10 26/10 - 01/11 09/11 - 15/11 23/11 - 29/11 07/12 - 13/12 21/12 - 27/12 04/01 - 10/01 18/01 - 24/01 01/02 - 07/02 15/02 - 21/02 01/03 - 07/03 15/03 - 21/03 29/03 - 04/04 12/04 - 18/04 26/04 - 02/05 10/05 - 16/05 24/05 - 30/05 07/06 - 13/06 21/06 - 27/06 05/07 - 11/07 19/07 - 25/07

Fig. 4. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period reported in Indonesia from 13 April 2020 (when Indonesia first reported community transmission in the country) to 25 July 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

Disclaimer: There are seven categories for transmission classification: (1) no (active) cases; (2) imported/sporadic cases; (3) cluster of cases; (4) community transmission 1 (CT1); (5) community transmission 2 (CT2); (6) community transmission 3 (CT3); and (7) community transmission 4 (CT4). Caution should be exercised when interpreting this indicator due to limitations listed in the WHO interim guidance. Other epidemiological indicators also need to be evaluated to decide on the level of community transmission. This disclaimer applies to indicators at national (Fig. 4) and subnational levels (Figs. 5 to 10).

7 Weekly incidence of COVID-19 is calculated as the number of new cases per 100 000 population per week averaged over a two-week period. Source of population data 5 WHO Indonesia Situation Report - 65 who.int/indonesia

• During the week of 19 to 25 July, only one province experienced low incidence of COVID-19 cases (CT1). Seven provinces, as opposed to six in the previous week, were at the highest level of community transmission (CT4) with the incidence rates per 100 000 population of 688.6 in DKI Jakarta, 362.9 in DI Yogyakarta, 248.9 in East Kalimantan, 213.3 in North Kalimantan, 208.1 in Riau Islands, 198.1 in West Papua and 178.0 in Bangka Belitung Islands (Fig. 5). Based on the WHO interim guidance, this meant that there was a very high risk of COVID-19 infection for the general public and a very high number of locally acquired, widely dispersed cases detected in the past 14 days.

DKI Jakarta DI Yogyakarta East Kalimantan North Kalimantan Riau Islands West Papua Bangka Belitung Islands Banten Bali West Java East Java East Nusa Tenggara Central Java Bengkulu West Sumatra Riau Central Kalimantan North Sulawesi Maluku Central Sulawesi West Kalimantan South Kalimantan South Sumatra Jambi South Sulawesi Papua West Sulawesi Gorontalo West Nusa Tenggara Lampung Aceh 0 100 200 300 400 500 600 700 Weekly case incidence

CT 1 (<20) CT 2 (20-<50) CT 3 (50 - <150) CT 4 (150+)

Fig. 5. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period by province in Indonesia during 19 to 25 July 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

6 WHO Indonesia Situation Report - 65 who.int/indonesia

• Java and Bali have been experiencing a steep increase in incidence rates since June. The weekly incidence of COVID-19 cases increased in six provinces during the week of 19 to 25 July (Fig. 6). Although DKI Jakarta reported a decrease in incidence, it remains at the highest level of community transmission scenario (CT4) in the last six weeks. DI Yogyakarta also remained to be at CT4 in the last three weeks.

Fig. 6. Incidence of COVID-19 cases per 100 000 population per week averaged over a two-week period in Java - Bali, from 13 April 2020 to 25 July 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

7 WHO Indonesia Situation Report - 65 who.int/indonesia

• In Sumatra, the weekly incidence of COVID-19 increased in all provinces, except f or Aceh, during the week of 19 to 25 July. There has been an increasing trend in incidence since April in most provinces. Bangka Belitung Islands and Riau Islands had experienced a consistent and substantial increase in weekly incidence reaching the highest transmission scenario (CT4). There has also been a recent surge in weekly incidence in North Sumatra, West Sumatra, Riau, Jambi, South Sumatra, Bengkulu and Lampung (Fig. 7).

Fig. 7. Incidence of COVID-19 cases per 100 000 population per week averaged over a two-week period in Sumatra, from 13 April 2020 to 25 July 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data 8

WHO Indonesia Situation Report - 65 who.int/indonesia

• In Kalimantan, the weekly incidence of COVID-19 increased in all provinces during the week of 19 to 25 July, similar to the previous week, with a rapid increase in cases since the end of June (Fig. 8). In particular, East Kalimantan and North Kalimantan experienced a substantial increase in cases and continued to be at the highest level of community transmission scenario (CT4) for the last two weeks.

Fig. 8. Incidence of COVID-19 cases per 100 000 population per week averaged over a two-week period in Kalimantan, from 13 April 2020 to 25 July 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

9 WHO Indonesia Situation Report - 65 who.int/indonesia • In Sulawesi, the incidence has been consistently increasing in all provinces since the end of May. The weekly incidence of COVID-19 cases increased in all provinces during the period of 19 to 25 July, in particular in North and Central Sulawesi (Fig. 9).

Fig. 9. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period in Sulawesi, from 13 April 2020 to 25 July 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

10 WHO Indonesia Situation Report - 65 who.int/indonesia • During the week of 19 to 25 July, the weekly incidence of COVID-19 increased in West Nusa Tenggara, East Nusa Tenggara, North Maluku, Papua and West Papua (Fig. 10).

Fig. 10. Incidence of COVID-19 cases per 100 000 population per week averaged over a two-week period in West Nusa Tenggara, East Nusa Tenggara, Maluku, North Maluku, Papua, and West Papua, from 13 April 2020 to 25 July 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

11 WH O Indonesia Situation Report - 65 who.int/indonesia

• Nationwide test positivity proportion increased sharply in December 2020; and reached the first peak of 30.5% in mid-February 2021. It slowly declined thereafter and remained between 9% and 20% between mid-March and end of June (corresponding to CT3 – high incidence). Since then, however, the positivity proportion has increased rapidly and steadily, reaching and remaining at the level CT4 (very high incidence) to date. As of 25 July, the positivity proportion was 29.0% (Fig. 11).

40%

35%

CT 4 (20%+) 30%

25%

20% CT 3 (5% - <20%)

15% Positivity proportion (%) proportion Positivity

10% CT 2 (2% - <5%) CT 1 (<2%) 5%

0% 1-May 1-Jun 1-Jul 1-Aug 1-Sep 1-Oct 1-Nov 1-Dec 1-Jan 1-Feb 1-Mar 1-Apr 1-May 1-Jun 1-Jul

Fig. 11. Test positivity proportion averaged over a two-week period at the national level in Indonesia, as of 25 July 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data Disclaimer: Caution should be exercised when interpreting this indicator due to limitations listed in the WHO interim guidance. Other epidemiological indicators also need to be evaluated to determine the level of community transmission.

• The percentage of positive samples can be interpreted reliably only with comprehensive surveillance and testing in the order of one person tested per 1000 population per week. This minimum case detection benchmark was achieved in DKI Jakarta, West Java, Central Java, DI Yogyakarta, Banten, West Sumatra, East Kalimantan, West Papua, Riau and Central Kalimantan for the last three weeks. Nevertheless, these provinces still have a test positivity proportion of more than 5%, which means that transmission is still very high in the community (Fig. 12).

12

WHO Indonesia Situation Report - 65 who.int/indonesia 24.0 70%

20.0 60% 50% 16.0 40% 12.0 30% 8.0 20%

4.0 10% (%) proportion Positivity 0.0 0% 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 People tested/1000 population/week Indonesia DKI West Central DI Yogyakarta East Banten Jakarta Java Java Java People tested/1000 population/week Test positivity proportion

24.0 70.0%

20.0 60.0% 50.0% 16.0 40.0% 12.0 30.0% 8.0 20.0%

4.0 10.0% (%) proportion Positivity 0.0 0.0% 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 People tested/1000 population/week Indonesia West East West Riau Central South Southeast Sumatra Kalimantan Papua Kalimantan Sumatra Sulawesi People tested/1000 population/week Test positivity proportion

Fig. 12. Test positivity proportion and people tested per 1000 population per week at the national level and in select provinces.

Week 1: 05/07/21 to 11/07/21; Week 2: 12/07/21 to 18/07/21; Week 3: 19/07/21 to 25/07/21 Benchmark: one person tested per 1000 population per week Threshold test positivity proportion: <5% Source of data: Indonesia, DKI Jakarta, West Java, Central Java, DI Yogyakarta, East Java, Banten, West Sumatra, East Kalimantan, West Papua, Riau, Central Kalimantan, South Sumatra, Southeast Sulawesi

Note: Due to a limitation in data, other provinces could not be evaluated. For surveillance purposes, test positivity proportion is calculated as the number of confirmed cases divided by the number of people tested for diagnosis.

13 WH O Indonesia Situation Report - 65 who.int/indonesia

• DI Yogyakarta continued to report the highest weekly number of confirmed COVID-19 deaths per 100 000 population, followed by East Kalimantan and DKI Jakarta. In addition, Riau Islands, Bangka Belitung Islands and Central Java reached CT4 over the past week (Fig. 13).

DI Yogyakarta East Kalimantan DKI Jakarta Riau Islands Bangka Belitung Islands Central Java East Java North Kalimantan Bali West Papua North Maluku Riau West Java Central Sulawesi South Sumatra West Kalimantan Maluku Central Kalimantan West Sumatra North Sulawesi South Kalimantan Lampung Southeast Sulawesi South Sulawesi East Nusa Tenggara Aceh Jambi West Sulawesi Gorontalo Banten Bengkulu West Nusa Tenggara North Sumatra Papua 0.0 2.0 4.0 6.0 8.0 10.0 12.0 Weekly number of confirmed COVID-19 deaths per 100 000 population

CT 1 (<1) CT 2 (1 - <2) CT 3 (2 - <5) CT 4 (5+)

Fig. 13. Number of confirmed COVID-19 deaths per 100 000 population per week averaged over a two-week period by province in Indonesia during 19 to 25 July 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

Disclaimer: Based on data availability, only confirmed COVID-19 deaths have been included. As per WHO definition, however, death resulting from a clinically compatible illness in a probable or confirmed COVID-19 case is a COVID-19-related death, unless there is a clear alternative cause of death that cannot be related to COVID-19 (e.g. trauma); there should be no period of complete recovery between the illness and death. Evaluation of excess mortality is also beneficial to complement information on COVID-19 death.

14 WHO Indonesia Situation Report - 65 who.int/indonesia

• At the national level, during the week of 19 to 25 July, the number of confirmed COVID-19 deaths increased from 2.09 deaths per 100 000 in the previous week to 2.83 per 100 000 population8. There was a steep increase in deaths throughout June, which has continued into July (Fig. 14).

3.0

2.5

2.0

1.5

1.0

0.5

Deaths per 100 0.0 000 population 13/04 - 19/04 27/04 - 03/05 11/05 - 17/05 25/05 - 31/05 08/06 - 14/06 22/06 - 28/06 06/07 - 12/07 20/07 - 26/07 03/08 - 09/08 17/08 - 23/08 31/08 - 06/09 14/09 - 20/09 28/09 - 04/10 12/10 - 18/10 26/10 - 01/11 09/11 - 15/11 23/11 - 29/11 07/12 - 13/12 21/12 - 27/12 04/01 - 10/01 18/01 - 24/01 01/02 - 07/02 15/02 - 21/02 01/03 - 07/03 15/03 - 21/03 29/03 - 04/04 12/04 - 18/04 26/04 - 02/05 10/05 - 16/05 24/05 - 30/05 07/06 - 13/06 21/06 - 27/06 05/07 - 11/07 19/07 - 25/07

Fig. 14. Number of confirmed COVID-19 deaths per 100 000 population per week averaged over a two-week period in Indonesia, as of 25 July 2021. Source of data

Disclaimer: Based on data availability, only confirmed COVID-19 deaths have been included. As per WHO definition, however, death resulting from a clinically compatible illness in a probable or confirmed COVID-19 case is a COVID-19-related death, unless there is a clear alternative cause of death that cannot be related to COVID-19 (e.g. trauma); there should be no period of complete recovery between the illness and death. Evaluation of the level of community transmission could not be conducted due to data limitations.

8 Weekly mortality of COVID-19 is calculated as the number of COVID-19 deaths per 100 000 population per week averaged over a two-week period. Source of population data 15 WHO Indonesia Situation Report - 65 who.int/indonesia • During the week of 19 to 25 July, the total number of weekly confirmed COVID-19 deaths in DKI Jakarta was 1230, the highest weekly number of deaths ever reported, and it increased almost two-fold when compared to the previous week (Fig. 15).

DKI Jakarta 1400 19 - 1200 1000 800 600 400

deaths 200 0 Weekly number number Weekly of confirmed COVID 02/03 - 08/03 30/03 - 05/04 27/04 - 03/05 25/05 - 31/05 22/06 - 28/06 20/07 - 26/07 17/08 - 23/08 14/09 - 20/09 12/10 - 18/10 09/11 - 15/11 07/12 - 13/12 04/01 - 10/01 01/02 - 07/02 01/03 - 07/03 29/03 - 04/04 26/04 - 02/05 24/05 - 30/05 21/06 - 27/06 19/07 - 25/07

Fig. 15. Weekly number of confirmed COVID-19 deaths in DKI Jakarta, as of 25 July 2021. Source of data

Disclaimer: The data are provisional. There may be a discrepancy in the number of deaths in confirmed COVID-19 cases between national and provincial data sources.

HEALTH OPERATIONS

• As of 28 July, the daily number of people tested for COVID 19 was 185 181 and the cumulative number of people tested was 17 374 182 (Fig. 16).

16 WHO Indonesia Situation Report - 65 who.int/indonesia 250000 20000000 18000000 200000 16000000 14000000 150000 12000000 10000000 100000 8000000

Daily number 6000000 Cumulative number 50000 4000000 2000000 0 0 3-Jul 7-Jun 2-Apr 7-Sep 8-Dec 23-Jul 26-Jul 7-Mar 23-Jan 30-Jun 10-Jun 23-Oct 22-Apr 25-Apr 30-Sep 15-Feb 31-Dec 15-Aug 15-Nov 30-Mar 10-Mar 15-May 18-May Daily number of people tested Cumulative number of people tested

Fig. 16. Daily and cumulative number of people tested for COVID-19 in Indonesia, as of 28 July 2021. Source of data

• As of 28 July, the proportion of people recovered among the total confirmed cases was 80.3% and there were 558 392 active cases (Fig. 17). 700000 100.0 90.0 600000 80.0 500000 70.0 400000 60.0 50.0

300000 40.0 Number

200000 30.0 (%) Percentage 20.0 100000 10.0 0 0.0 2-Jul 5-Jul 2-Jan 9-Jun 2-Oct 1-Apr 4-Apr 9-Sep 25-Jul 28-Jul 25-Jan 12-Jun 25-Oct 24-Apr 27-Apr 17-Feb 10-Dec 17-Aug 17-Nov 12-Mar 17-May 20-May Active cases Recovery percentage

Fig. 17. Number of active cases of COVID-19 and recovery percentage in Indonesia, as of 28 July 2021. Source of data 17 WH O Indonesia Situation Report - 65 who.int/indonesia

• The reported number of confirmed cases hospitalized in DKI Jakarta increased sharply in June and the beginning of July, reaching to the highest recorded number of hospitalizations (30 418) on 7 July. It has since decreased slightly to 15 168 hospitalizations on 25 July. The previous high was 9888 hospitalized cases reported on 12 February (Fig. 18).

35000 19 - 30000

25000

20000

15000

10000 cases hospitalizedcases 5000 Number of confirmed COVID 0 1-Oct 1-Nov 1-Dec 1-Jan 1-Feb 1-Mar 1-Apr 1-May 1-Jun 1-Jul

Fig. 18. Number of confirmed COVID-19 cases hospitalized in DKI Jakarta f rom 1 September 2020 to 25 July 2021. Source of data

LABORATORY

• On 24 July, WHO conducted a technical meeting inviting 60 participants from the Ministry of Health (MoH), the genomic surveillance laboratory network, and relevant partners. The objectives were to strengthen the coordination among relevant stakeholders, the national genomic surveillance system and improve the

procedures of national genomic surveillance and sequence activities to monitor SARS-CoV-2 variants. WHO presented a draft genomic surveillance guidance which promotes quality, timely and continuous genomic surveillance. The draft also includes methods on how to perform genomic characterization by combining epidemiological and laboratory data.

18 WHO Indonesia Situation Report - 65 who.int/indonesia

RISK COMMUNICATION

• WHO is regularly translating and sharing important health messages on its website and social media platforms – Twitter and Instagram – and has recently published:

Infographics: - Young people and COVID-19

Fig. 19. WHO infographics on Young people and COVID-19, July 2021.

RISK AND NEEDS ASSESSMENT, AND PLANNING

• On 8 and 9 July, WHO assisted MoH in conducting a refresher training on Influenza Like Illness (ILI) sentinel surveillance. The training was attended by over 100 participants from 31 ILI sentinel surveillance sites across Indonesia as well as representatives from PHOs and District Health Offices (DHOs). The training covered the national programme policy on acute respiratory infection/influenza, Early Warning Alert and Response System (EWARS), the standard operating procedure (SOP) for ILI sentinel surveillance and procedures of sample collection

and shipment. WHO presented the global situation updates on influenza and COVID-19 and how to use the Global Influenza Surveillance and Response 19 WHO Indonesia Situation Report - 65 who.int/indonesia System (GISRS) for monitoring of SARS-CoV-2. Some challenges identified during the training included delays in shipment of samples and the decrease in the number of outpatients reported in ILI sentinel sites.

• On 30 June, WHO participated in a meeting organized by the Coordinating Ministry for Human Development and Cultural Affairs on the improvement of COVID-19 contact tracing, testing and vaccination through community empowerment. The meeting discussed challenges and the need for response planning to improve tracing, community-based surveillance and vaccination. WHO emphasized the value of building community resilience as part of the COVID-19 pandemic response and promoted community engagement for immediate and dynamic risk and vulnerability mapping and scaling up operational readiness. In addition, WHO highlighted the importance of synchronizing the community-based surveillance system initiated by CSOs with the existing reporting system in community health centres (puskesmas) to ensure streamlined data and analysis.

VACCINATION

• As of 26 July, 63 379 747 vaccine doses have been administered in the national COVID-19 vaccination campaign; 45 012 649 people have received the first dose and 18 367 098 people have received the second dose (Fig. 20).

20 WHO Indonesia Situation Report - 65 who.int/indonesia 50000000

40000000

30000000

20000000

Number vaccinated 10000000

0 2/5/2021 3/5/2021 4/2/2021 4/9/2021 5/7/2021 6/4/2021 7/2/2021 7/9/2021 1/22/2021 1/29/2021 2/12/2021 2/19/2021 2/26/2021 3/12/2021 3/19/2021 3/26/2021 4/16/2021 4/23/2021 4/30/2021 5/14/2021 5/21/2021 5/28/2021 6/11/2021 6/18/2021 6/25/2021 7/16/2021 7/23/2021

Cumulative 1st dose vaccination Cumulative 2nd dose vaccination

Fig. 20. Cumulative number of vaccine doses administered in Indonesia, from 22 January to 26 July 2021. Source of data

Disclaimer: COVID-19 vaccination started on 13 January. Published data from MoH is available starting from 22 January.

• As of 26 July, the number of older people who have received the first dose of the COVID-19 vaccine was 4 780 438 (22.2% of the targeted 21 553 118); only

3 073 295 (14.3% of the target population of older people) have received the second dose (fully vaccinated). The number of essential public service workers who have received the second dose was 10 546 910 (60.9% of the target population of 17 327 167). Among them, 2 206 528 teachers (39% of the targeted 5 659 560) have received the first dose and 1 686 160 (29.8% of targeted population) have received the second dose. The number of people from vulnerable populations and those aged 18 years and older who have received the first dose was 12 905 752 (9.1% of the targeted 141 211 181); 3 298 402 (2.3% of the targeted population) have received the second dose. The number of health workers who have received the second dose was 1 448 425 (98.6% of the target population of 1 468 764) (Fig. 21).

21 WHO Indonesia Situation Report - 65 who.int/indonesia Children (aged 12- 746811 17 years) 66

Health Workers 1592432 1448425 1st dose Older people 4780438 3073295 2nd dose Vulnerable 12905752 population &… 3298402 Essential public 24987216 service workers 10546910

0 5000000 10000000 15000000 20000000 25000000

Number of people who have received COVID-19 vaccine

Fig. 21. Cumulative number of people who have received COVID-19 vaccine in Indonesia, as of 26 July 2021. Source of data

Disclaimer: COVID-19 vaccination started with health workers on 13 January. The second stage of COVID-19 vaccination started on 17 February, targeting essential public service workers and older people (above 60 years old). Published data from MoH is available starting from 22 January. Vaccination coverage over 100% is due to differences in actual versus estimated target population.

• As of 26 July, provinces with the highest percentage of unvaccinated (zero dose) health workers were Papua, Maluku and Central Sulawesi (Fig. 22). The situation

remained the same since the previous week.

22 WHO Indonesia Situation Report - 65 who.int/indonesia Papua Maluku Central Sulawesi Gorontalo North Maluku Aceh Bengkulu West Sulawesi North Kalimantan Jambi West Papua South Sumatera South Sulawesi Southeast Sulawesi North S ulawesi East Kalimantan South Kalimantan Central Kalimantan West Kalimantan East Nusa Tenggara West N us a… Bali Ba nten East Java DI Yogyakarta Central Java West Java DKI Jakarta Riau Islands Bangka Belitung… Lampung Riau West Sumatera North Sumatera

0% 5% 10% 15% 20% 25%

Unvaccinated

Fig. 22. Percentage of unvaccinated health workers by province in Indonesia, as of 26 July 2021. Source of data

• As of 26 July, Bali was the province with the highest first-dose vaccination coverage among all eligible target populations (health workers, older people, essential public service workers, vulnerable populations, children aged 12-17 years and people aged 18 and above), followed by DKI Jakarta, Riau Islands, DI Yogyakarta and North Sulawesi. As of the same day, DKI Jakarta had the highest second-dose vaccination coverage among the same target groups, followed by Bali, DI Yogyakarta, Riau Islands and Central Kalimantan (Fig. 23).

23 WHO Indonesia Situation Report - 65 who.int/indonesia 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%

Vaccination coverage (%) coverage Vaccination 0% Bali Riau Aceh Jambi Papua Ba nten Maluku East Java East Lampung Bengkulu West Java Gorontalo DKI Jakarta Riau Islands Riau Central Java Central West Papua West DI Yogyakarta North Maluku North West Sulawesi South Sulawesi South North S ulawesi West Sumatera West North Sumatera North East Kalimantan South Sumatera South Central Sulawesi West Kalimantan South Kalimantan North Kalimantan Southeast Sulawesi Central Kalimantan East Nusa Tenggara West Nusa Tenggara Bangka Islands Bangka Belitung 1st dose cov erage (%) 2nd dose coverage (%) Target

Fig. 23. COVID-19 vaccination coverage among all eligible target population by province in Indonesia, as of 26 July 2021. Source of data.

Disclaimer: Vaccination coverage has been adjusted according to the updated denominator published by the Ministry of Health. Published data from MoH includes target populations of the third stage of national vaccination campaign, which was available starting from 13 July 2021.

• As of 26 July, the number of people who received two doses (fully vaccinated) per 100 population was 6.7 nationwide; and DKI Jakarta reported the highest number of people fully vaccinated (20.7 per 100 population) amongst all provinces, followed by Bali (17.8), Riau Islands (8.7), Central Kalimantan (8.3) and East Kalimantan (7.9) (Fig. 24).

24 WHO Indonesia Situation Report - 65 who.int/indonesia Fig. 24. Number of people vaccinated with two COVID-19 vaccine doses (fully vaccinated) per 100 population by province in Indonesia, as of 26 July 2021. Source of data

• As of 26 July, DKI Jakarta reported the highest first-dose vaccination coverage among older people, followed by Bali, DI Yogyakarta and Riau Islands. As of the same day, DKI Jakarta reported the highest second-dose vaccination coverage among this target group, followed by DI Yogyakarta, Bali and Riau Islands (Fig. 25). As of the same day, provinces with the highest percentage of unvaccinated (zero dose) older people were Aceh, North Maluku and West Sumatra (Fig. 26). 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% Vaccination coverage (%) coverage Vaccination 0% Bali Riau Aceh Jambi Papua Ba nten Maluku East Java East Lampung Bengkulu West Java Gorontalo DKI Jakarta Riau Islands Riau Central Java Central West Papua West DI Yogyakarta North Maluku North West Sulawesi South Sulawesi South North S ulawesi West Sumatera West North Sumatera North East Kalimantan South Sumatera South Central Sulawesi West Kalimantan South Kalimantan North Kalimantan Southeast Sulawesi Central Kalimantan East Nusa Tenggara West Nusa Tenggara Bangka Islands Bangka Belitung 1st dose (coverage) 2nd dose (coverage) Target (coverage) Fig. 25. COVID-19 vaccination coverage among older people by province in Indonesia, as of 26 July 2021. Source of data

Disclaimer: Vaccination coverage for older people has been adjusted according to the published data which was available starting 13 July 2021. 25 WHO Indonesia Situation Report - 65 who.int/indonesia

Aceh North Maluku West Sumatera Papua Lampung West Papua West Sulawesi Southeast Sulawesi Central Sulawesi South Kalimantan East Nusa Tenggara West Kalimantan Gorontalo South Sulawesi Maluku Riau West Nusa Tenggara South Sumatera Bengkulu West Java Ba nten North Sumatera East Java North Kalimantan Jambi East Kalimantan Bangka Belitung Islands North S ulawesi Central Kalimantan Central Java Riau Islands DI Yogyakarta Bali DKI Jakarta

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

Unvaccinated Fig. 26. Percentage of unvaccinated older people (over 60 years of age) by province in Indonesia, as of 26 July 2021. Source of data

• As of 26 July, DKI Jakarta reported the highest first-dose vaccination coverage among vulnerable populations and people above 18 years of age, followed by Bali, Riau Islands and North Sulawesi. As of the same day, DKI Jakarta reported the highest second-dose vaccination coverage among this target group, followed by Bali, Riau Islands, Riau and East Java (Fig. 27).

26 WHO Indonesia Situation Report - 65 who.int/indonesia

100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Vaccination coverage (%) coverage Vaccination Bali Riau Aceh Jambi Papua Ba nten Maluku East Java East Lampung Bengkulu West Java Gorontalo DKI Jakarta Riau Islands Riau Central Java Central West Papua West DI Yogyakarta North Maluku North West Sulawesi South Sulawesi South North S ulawesi West Sumatera West North Sumatera North East Kalimantan South Sumatera South Central Sulawesi West Kalimantan South Kalimantan North Kalimantan Southeast Sulawesi Central Kalimantan East Nusa Tenggara West Nusa Tenggara Bangka Islands Bangka Belitung 1st dose (coverage) 2nd dose (coverage) Target (coverage)

Fig. 27. COVID-19 vaccination coverage among vulnerable and high-risk populations and general population by province in Indonesia, as of 26 July 2021. Source of data

Disclaimer: Indonesia kicked-off the third stage of the national COVID-19 vaccination campaign targeting vulnerable populations and people above 18 years of age in 5 May 2021. Published data from MoH is available starting 13 July 2021.

• As of 26 July, DKI Jakarta reported the highest first-dose vaccination coverage among children (aged 12 to 17 years), followed by Bali, Riau Islands and

DI Yogyakarta (Fig. 28).

27 WHO Indonesia Situation Report - 65 who.int/indonesia 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Vaccination coverage (%) coverage Vaccination Bali Riau Aceh Jambi Papua Ba nten Maluku East Java East Lampung Bengkulu West Java Gorontalo DKI Jakarta Riau Islands Riau Central Java Central West Papua West DI Yogyakarta North Maluku North West Sulawesi South Sulawesi South North S ulawesi West Sumatera West North Sumatera North East Kalimantan South Sumatera South Central Sulawesi West Kalimantan South Kalimantan North Kalimantan Southeast Sulawesi Central Kalimantan East Nusa Tenggara West Nusa Tenggara Bangka Islands Bangka Belitung 1st dose (coverage) 2nd dose (coverage) Target (coverage)

Fig. 28. COVID-19 vaccination coverage among children (aged 12 to 17 years) by province in Indonesia, as of 26 July 2021. Source of data

Disclaimer: COVID-19 vaccination targeting children started on 1 July 2021. Published data from MoH is available starting 13 July 2021.

PARTNER COORDINATION

• On 23 July, WHO convened the 34th meeting of key development partners to discuss and coordinate the COVID-19 response in Indonesia. The meeting was attended by the Asian Development Bank (ADB), British Embassy, the Australian Government Department of Foreign Affairs and Trade (DFAT), the European Union (EU), International Cooperation Agency (JICA), United Children’s Fund (UNICEF), United States Agency for International Development (USAID), United States Centers for Disease Control and Prevention (US CDC), the World Bank and the World Food Programme (WFP). WHO presented COVID-19 updates, discussed the latest epidemiological situation at national and subnational levels, and presented the key WHO activities in support of the national pandemic response. They also discussed updates on the national COVID-19 vaccination campaign and potential support for oxygen and other medical supplies.

28 WHO Indonesia Situation Report - 65 who.int/indonesia • The overall funding request for WHO operations and technical assistance is US$ 46 million (US$ 27 million for response and US$ 19 million for recovery phase), based on estimated needs as of July 2021 (Fig. 29).

Fig. 29. WHO funding situation for COVID-19 response, July 2021.

Data presented in this situation report have been taken from publicly available data from the MoH (https://infeksiemerging.kemkes.go.id/), COVID-19 Mitigation and National Economic Recovery Team (KPCPEN) (http://covid19.go.id) and provincial websites. There may be differences in national and provincial data depending on the source used. All data are provisional and subject to change.

29 WHO Indonesia Situation Report - 65 who.int/indonesia COVID-19 AND MOBILITY ANALYSIS

• Mobility analysis can be used as a proxy to monitor population mobility during the implementation of movement restriction policies during the COVID-19 pandemic. Increased mobility may lead to increased interactions among people, which may affect COVID-19 transmission. Mobility of populations can be measured using several approaches9. More information on the movement restriction policies that have been implemented in Indonesia and previous analyses on mobility trends in Java and Bali is available on WHO Situation Report 63 (pages 27-31) and Situation Report 64 (pages 34-38). Updates on mobility analysis in provinces in Java and Bali, as of 22 July, are presented in figures 30 to 36.

• On 26 July, the Government of Indonesia had lifted some of the movement restrictions during the emergency PPKM, which included restrictions on travel as well as traditional markets and small and medium enterprises (SMEs). This may result in increased mobility, therefore, its impact on the transmission needs to be carefully monitored in the coming weeks.

Fig. 30. Mobility analysis in DKI Jakarta, as of 22 July 2021

Holiday periods: 1. Eid al-Fitr 2020; 2. Eid al-Adha 2020; 3. (Prophet ’s Birthday) 2020; 4. Christmas and New Year 2021; 5. Eid al-Fitr 2021.

Note: The baseline day is the median value from the 5-week period from 3 January to 6 February 2020 (prior to the first reported cases in Indonesia). Mobility is calculated for the report date (unless there are gaps) and reported as a positive or negative percentage change compared to the baseline day. Source of data: mobility; cases. Mobility analysis cannot demonstrate a cause and effect relationship between mobility and COVID-19 Disclaimer: cases; interpretation should be based on the use of proxy measures for mobility to examine association with cases. 9 For purposes of current analysis in Indonesia, COVID-19 Community Mobility Reports (Google) have been used. This note and disclaimer apply to Figs. 30-36. 30 WHO Indonesia Situation Report - 65 who.int/indonesia

Fig. 31. Mobility analysis in West Java, as of 22 July 2021. Source of data: mobility; cases.

Fig. 32. Mobility analysis in Central Java, as of 22 July 2021. Source of data: mobility; cases.

31 WHO Indonesia Situation Report - 65 who.int/indonesia

Fig. 33. Mobility analysis in DI Yogyakarta, as of 22 July 2021. Source of data: mobility; cases.

Fig. 34. Mobility analysis in East Java, as of 22 July 2021. Source of data: mobility; cases.

32 WHO Indonesia Situation Report - 65 who.int/indonesia

Fig. 35. Mobility analysis in Banten, as of 22 July 2021. Source of data: mobility; cases.

Fig. 36. Mobility analysis in Bali, as of 22 July 2021. Source of data: mobility; cases.

33 WHO Indonesia Situation Report - 65 who.int/indonesia WEEKLY RISK ASSESSMENT

Table 1. Weekly risk assessment by province in Indonesia, as of 25 July 2021.

Source of data: Cases, deaths and testing; vaccination Note: Case incidence considers the trend of cases over the last three weeks. The change in new cases in the last seven days is marked as light red if there is an increase of 50% compared to the previous week. The change in new deaths is marked as light red if there is any increase in the percentage of deaths (and number of deaths ≥ 10) compared to the previous week. The testing rate is marked as yellow if it is less than 1/1000 population. Test positivity proportion is marked as light red if ≥ 20% and yellow if between 5% and 20%. The second dose vaccination is marked as light red if < 5% and yellow if between 5% and 10%. Target population for vaccination includes health workers, essential public service workers, older persons, vulnerable populations and people above 18 years of age and children (aged 12-17 years).

34 WHO Indonesia Situation Report – 65 who.int/indonesia • Urgent action is needed to address the continuing surge of cases, notably in provinces in light red (West Sumatra, South Sumatra, Bangka Belitung Islands, Riau Islands, DKI Jakarta, West Java, Central Java, DI Yogyakarta, East Java, Banten, Bali, East Kalimantan and North Maluku) and in yellow. Bed occupancy rate has also been reported to be high in these provinces and is considered in the risk assessment.10,11,12,13

• Strict implementation of PHSM throughout the country is crucial, even as the national vaccination coverage increases and expands to additional target groups. PHSM works in the context of variants of concern (VOCs) as demonstrated in (see Situation Report 60: Lessons Learned) and other countries that are facing a surge of cases. Considering that some VOCs have much higher transmissibility, timely adjustments of PHSM is very important during a surge, including the use of stringent measures (such as movement restrictions) as quickly as possible.14

• During the period of 19 to 25 July 2021, Indonesia submitted a total of 376 genetic sequence data to the Global Initiative on Sharing All Influenza Data (GISAID) platform. These sequenced samples were collected in various times in Aceh, Bali, Banten, Central Java, DKI Jakarta, East Java, Aceh, Bali, Banten, Central Java, DKI Jakarta, East Kalimantan, East Nusa Tenggara, Jambi, Riau Islands, South Sumatra and West Java. The Delta variant was reported from samples collected in March-July 2021, with a total number of 121 cases. The majority of cases were reported in East Nusa Tenggara, West Java and Central Java. These data should be interpreted with caution as several factors such as the sampling strategy, number of specimens collected, and sample collection dates need to be considered.

Table 2. Number of the Delta variant reported by province in Indonesia, as of 25 July 2021. Source of data Number of whole Number of No. Provinces genomic sequencing cases (WGS) performed 1. DKI Jakarta 296 865 2. West Java 257 786 3. Central Java 156 235 4. East Nusa Tenggara 41 67 5. North Sumatera 20 98

10 https://www.thejakartapost.com/news/2021/07/27/death-haunts-self-isolating-patients-as-covid-19-tsunami- engulfs-indonesia.html 11 https://jakartaglobe.id/news/daily-covid-death-toll-passes-2000-for-first-time 12 https://www.suara.com/news/2021/07/27/201715/indonesia-peringkat-1-dunia-kasus-harian-covid-19- terbanyak-tambah-45203-kasus 13 https://www.liputan6.com/health/read/4617166/tingkat-keterisian-tempat-tidur-pasien-covid-19-di-rumah- sakit-sumbar-capai-77-persen 14 https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance-publications 35 WHO Indonesia Situation Report – 65 who.int/indonesia 6. DI Yogyakarta 20 77 7. Banten 17 170 8. West Nusa Tenggara 16 28 9. East Java 14 181 10. East Kalimantan 13 35 11. South Sulawesi 11 60 12. South Sumatera 10 43 13. Papua 10 23 14. Bali 8 421 15. North Kalimantan 8 19 16. Jambi 7 105 17. Central Kalimantan 4 37 18. Bengkulu 3 8 19. Lampung 3 10 20. Riau Islands 2 120 21. Gorontalo 1 3 22. West Sulawesi 1 23

• During the implementation of emergency PPKM, testing rates increased in some provinces and districts; however, other provinces such as Aceh, Lampung, West Nusa Tenggara and Southeast Sulawesi continue to experience challenges in meeting the recommended benchmark of 1 suspected case tested per 1000 population per week. Testing services should be further strengthened across these provinces. Early diagnosis of cases is a backbone of public health response to COVID-19, as it enables timely isolation of cases, tracing and quarantine of contacts.

• Strengthening genomic surveillance and investigation of clusters are also highly important when cases with Variants of Concern are suspected/confirmed.

• There is a need for hospitals to be equipped for the surge in cases, including ensuring the availability of isolation rooms, oxygen supplies, medical equipment, key therapeutics (e.g. corticosteroids, low-dose anticoagulants, antifungal medicines, and interleukin-6 receptor blockers), personal protective equipment (PPE), mobile field hospitals, body bags, as well as additional human resources and capacity to convert hospital rooms to isolation or intensive care unit (ICU) rooms.15

• Community engagement and support (strict implementation of personal protective measures) are essential to reducing the surge in cases, deaths and

15 https://www.who.int/publications/i/item/critical-preparedness-readiness-and-response-actions-for-covid-19 36 WHO Indonesia Situation Report – 65 who.int/indonesia hospitalizations. It is important to provide accurate and tailored information and recommendations in order to counter misinformation and hoaxes.

• Vaccination needs to be expedited, especially for older populations with limited coverage. Several provinces recorded the second-dose vaccination coverage below 5% among older populations, including Aceh, West Sumatra, North Maluku, Papua, West Sulawesi, Southeast Sulawesi, Gorontalo, West Papua, Lampung, Central Sulawesi and East Nusa Tenggara. Actions to improve accessibility and awareness on the benefits of COVID-19 vaccination for older and vulnerable populations need to be strengthened. Moreover, vaccinated people should continue to adhere to PHSM.

• Health facilities should continue to adhere to key WHO recommended IPC measures, in particular to contact, droplet and airborne precautions, hand hygiene practices, adequate environmental cleaning and disinfection, and ensuring adequate ventilation in rooms.

37 WHO Indonesia Situation Report – 65 who.int/indonesia

RECENT AND UPCOMING WHO RESOURCE MATERIALS Table 3. Title and details of recent WHO resource materials

Source : https://www.who.int Title Details WHO Weekly This edition includes data as of 25 July 2021. Two special focus Epidemiological updates provided in this edition include: (i) evaluation of Update on COVID-19 COVID-19 vaccines and their effectiveness in real world (Edition 50), settings and (ii) overview of SARS-CoV-2 variants and their 27 July 2021 geographic distribution.

Guidance on WHO recently made available interim guidance on best conducting vaccine practices for undertaking vaccine effectiveness evaluations: effectiveness Evaluation of COVID-19 Vaccine Effectiveness: Interim evaluations in the Guidance. Those recommendations still apply for undertaking setting of new vaccine effectiveness evaluations against new variants. SARS-CoV-2 Vaccine effectiveness evaluations of new variants may need variants: Interim approaches not described in the interim guidance. This guidance, 22 July addendum addresses aspects of undertaking vaccine 2021. Addendum to effectiveness evaluations for new variants. Evaluation of COVID-19 vaccine effectiveness, 23 July 2021

38 WHO Indonesia Situation Report – 65 who.int/indonesia A SNAPSHOT OF WHO COURSES AND INFORMATION MATERIAL

Online WHO COVID-19 courses: • COVID-19 vaccination training for health workers • Standard precautions: Environmental cleaning and disinfection • Management of COVID-19 in long-term care facilities • Operational planning guidelines and COVID-19 • Clinical management of severe acute respiratory infections • Health and safety briefing for respiratory diseases – eProtect

WHO guidance: • Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection • WHO technical consultation on oxygen access scale-up for COVID-19 • Safe Eid al Adha practices in the context of COVID-19

Infographics: • Managing COVID-19 at home: Checking blood oxygen levels • 5 Steps for managing patients with COVID-19 at home: Tips for health care providers • 5 Steps for managing patients with COVID-19 at home: for the public • COVID-19 vaccine and vaccination

Questions and answers: • How to talk about vaccines • COVID-19: Vaccines • COVID-19: Vaccine research and development • COVID-19: Vaccine access and allocation

Videos: • Science in 5: Evolution of the SARS-CoV-2 virus • Time to abide (1-10) • COVID-19 virus variants

For more information please feel free to contact: [email protected] WHO Indonesia Reports

39 WHO Indonesia Situation Report – 65 who.int/indonesia